摘要
目的 探索肝龙胶囊对四氯化碳(CCl_(4))诱导的肝纤维化(HF)大鼠的影响及其可能的作用机制。方法 将48只SPF级SD大鼠随机分为正常组、模型组、对照组和低、中、高剂量实验组,每组8只,除正常组外,其余组大鼠均腹腔注射40%CCl_(4)构建HF大鼠模型。造模成功后,正常组和模型组均给予等量0.9%NaCl;对照组给予0.2 mg·kg^(-1)秋水仙碱溶液;低、中、高剂量实验组分别给予62.5,125.0和250.0 mg·kg^(-1)肝龙胶囊溶液。6组大鼠每天灌胃给药1次,连续4周。用酶联免疫吸附法检测血清中HF 4项和肝组织中炎症因子的含量,用蛋白质印迹法检测B淋巴细胞瘤-2基因(Bcl-2)、Bcl-2相关X蛋白(Bax)和半胱氨酸天冬氨酸蛋白酶3(Caspase3)的表达水平,用实时荧光定量法检测α-平滑肌肌动蛋白(α-SMA)、Ⅰ型胶原(COL-Ⅰ)和COL-Ⅲ的表达水平。结果 高剂量实验组、对照组和模型组的谷草转氨酶分别为(21.07±4.50),(20.34±3.72)和(37.88±16.30)U·L^(-1);谷丙转氨酶分别为(4.03±1.16),(7.76±7.00)和(16.43±8.39)U·L^(-1);肿瘤坏死因子-α分别为(34.93±16.44),(50.38±4.81)和(86.45±6.39)ng·L^(-1);白细胞介素-1β分别为(11.37±7.96),(15.95±4.08)和(35.12±15.31)ng·L^(-1);Bax蛋白相对表达水平分别为0.09±0.01,0.13±0.03和0.30±0.16;Bcl-2蛋白相对表达水平分别为0.11±0.01,0.09±0.01和0.08±0.01;Caspase3蛋白相对表达水平分别为0.16±0.04,0.22±0.04和0.43±0.07;α-SMA mRNA表达水平分别为2.25±1.31,2.74±1.60和8.56±4.73;COL-Ⅰ mRNA表达水平分别为1.31±0.82,5.54±2.75和7.86±4.53;COL-Ⅲ mRNA表达水平分别为1.91±1.40,3.80±2.12和5.24±3.58。高剂量实验组的上述指标与模型组比较,差异均有统计学意义(均P<0.05)。结论 肝龙胶囊通过控制炎症水平,抑制肝细胞凋亡,抑制胶原的合成与分泌等作用,来改善肝损伤,缓解肝纤维化。
Objective To investigate the effect of Ganlong capsule on carbon tetrachloride (CCl_(4))-induced hepatic fibrosis (HF) in rats and its possible mechanism.Methods A total of 48 SPF SD rats were randomly divided into normal,model,control groups and experimental-L,-M,-H groups,with 8 rats in each group.Except for normal group,the rats in other groups were intraperitoneally injected with 40%CCl_(4)to construct HF rat model.After successful modeling,the normal group and model group were given 0.9%Na Cl.The control group was gavaged 0.2 mg·kg^(-1)colchicine solution.Six groups were given corresponding drugs once a day for 4 weeks.The four HF indexes and inflammatory factors in the liver tissue were detected by enzyme linked immunosorbent assay.The expression levels of Blymphoblastoma-2 gene (Bcl-2),Bcl-2 associated X protein (Bax) and cysteine aspartate protease 3 (Caspase3)were detected by Western blotting.The expression levels of α-smooth muscle actin (α-SMA),typeⅠcollagen(COL-Ⅰ) and typeⅢcollagen (COL-Ⅲ) were detected by real-time fluorescence quantification.Results In experimental-H,control and model groups,glutamic oxalacetic transaminase were (21.07±4.50),(20.34±3.72)and (37.88±16.30) U·L^(-1);glutamic-pyruvic transaminase were (4.03±1.16),(7.76±7.00) and (16.43±8.39)U·L^(-1);tumor necrosis factor-α were (34.93±16.44),(50.38±4.81) and (86.45±6.39) ng·L^(-1);interleukin-1β were (11.37±7.96),(15.95±4.08) and (35.12±15.31) ng·L^(-1);the expression levels of Bax protein were 0.09±0.01,0.13±0.03 and 0.30±0.16;the expression levels of Bcl-2 protein were 0.11±0.01,0.09±0.01 and 0.08±0.01;the expression levels of Caspase3 protein were 0.16±0.04,0.22±0.04 and0.43±0.07;the expression levels of α-SMA mRNA were 2.25±1.31,2.74±1.60 and 8.56±4.73;the expression levels of COL-ⅠmRNA were 1.31±0.82,5.54±2.75 and 7.86±4.53;the expression levels of COL-ⅢmRNA were 1.91±1.40,3.80±2.12 and 5.24±3.58.The differences were statistically significant between experimental-H group and model group (all P<0.05).Conclusion Ganlong capsule can improve liver injury and alleviate HF by controlling inflammation level,inhibiting apoptosis of liver cells,inhibiting synthesis and secretion of collagen,and so on.
作者
周杰
单婉歆
欧玲
李银蕊
吕长玲
吴定宇
彭芳
ZHOU Jie;SHAN Wan-xin;OU Ling;LI Yin-rui;LüChang-ling;WU Ding-yu;PENG Fang(College of Pharmacy,Dali University,Dali 671000,Yunnan Province,China;Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical Research and Developing,Dali University,Dali 671000,Yunnan Province,China;College of Life Science and Engineering,Southwest Jiaotong University,Chengdu 610031,Sichuan Province,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2023年第4期513-517,共5页
The Chinese Journal of Clinical Pharmacology
基金
国家自然科学基金资助项目(81560600)
云南省应用基础研究重点基金资助项目(2017FH001-010)。
关键词
肝龙胶囊
四氯化碳
肝纤维化
炎症
细胞凋亡
Ganlong capsule
carbon tetrachloride
liver fibrosis
inflammation
cell apoptosis